Tata Elxsi and Terumo Corporation Join Forces
On March 19, 2026, Tata Elxsi, a leader in design and technology services, announced the opening of a new Offshore Development Center (ODC) specifically for Terumo Corporation, a prominent innovator in the medical field, particularly in cardiac and vascular solutions. This partnership marks a significant step in enhancing engineering and innovation capabilities while ensuring comprehensive lifecycle support for international markets.
The newly inaugurated 'Terumo–Tata Elxsi Offshore Development Center' aims to merge the strengths of both companies in a bid to meet the evolving demands of healthcare. By leveraging Tata Elxsi's extensive expertise in various domains such as design, engineering, verification, regulatory compliance, and localization, the center seeks to expedite product development. The thoughtful integration of AI, Generative AI, and digital capabilities in software engineering plays a critical role in adapting to regional needs and improving the efficiency of patient-centered medical devices.
With a growing global need for reliable and efficient medical technologies, this collaboration aims to enhance the performance and availability of cardiac and vascular products, ensuring they comply with industry standards and cater to the dynamic needs of healthcare professionals and their patients.
Fumihisa Hirose, President of the Cardiac Vascular Company at Terumo Corporation, emphasized the positive impact of the ODC on their innovation roadmap. He stated,
“This new Offshore Development Center strengthens our ability to innovate faster and deliver high-quality medical technologies across global markets. Tata Elxsi's integrated design, engineering, and regulatory expertise will help us accelerate our global product roadmap while maintaining the highest standards of safety and compliance.” This showcases Terumo's strategic commitment to expanding its offerings and improving safety in healthcare.
Adding to this sentiment, Sreevatsa Sahasranaman, Senior Vice President and Head of Healthcare and Life Sciences at Tata Elxsi, remarked that the Offshore Development Center reflects a robust and enduring partnership with Terumo. He mentioned,
“This Offshore Development Center represents a comprehensive long-term partnership model with Terumo Corporation to bring Tata Elxsi's multi-disciplinary, cross-functional, and deep domain expertise to drive innovation and cost efficiencies across Terumo's Cardiovascular portfolio.”
The collaboration serves as a promising model for future partnerships that blend design, engineering, and regulatory capabilities while enhancing next-generation medical technologies. Essentially, it emphasizes the importance of fusing traditional engineering with groundbreaking technologies like AI and Generative AI, aligning more closely with the needs of global healthcare markets.
About Tata Elxsi
Tata Elxsi is not just a design and technology services company but is also a catalyst for innovation across several industries including healthcare, automotive, broadcast, and communications. With its headquarters in Bangalore, Tata Elxsi operates through numerous design studios, development centers, and innovation hubs worldwide. Their Healthcare and Life Sciences practice is not only ISO 13485 certified but also collaborates extensively with leading medical device and pharmaceutical companies in creating next-generation products tailored for market success.
For more detailed information about Tata Elxsi, please visit their official website at
www.tataelxsi.com.